Report overview
Adeno-associated viruses?(AAV) are small?viruses?that infect humans and some other?primate species. They belong to the?genus?Dependoparvovirus, which in turn belongs to the?family?Parvoviridae. They are small (20?nm)?replication-defective,?nonenveloped viruses?and have linear single-stranded?DNA?(ssDNA) genome of approximately 4.8?kilobases?(kb).
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus Vectors in Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus Vectors in Gene Therapy. This report contains market size and forecasts of Adeno-Associated Virus Vectors in Gene Therapy in global, including the following market information:
Global Adeno-Associated Virus Vectors in Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Adeno-Associated Virus Vectors in Gene Therapy companies in 2022 (%)
The global Adeno-Associated Virus Vectors in Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Serotype 2 (AVV 2) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adeno-Associated Virus Vectors in Gene Therapy include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics, MeiraGTx, Neurocrine Biosciences, Pfizer, Roche Holding and Sangamo Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adeno-Associated Virus Vectors in Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Serotype 2 (AVV 2)
Synthetic Serotypes
Others
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Alzheimer's Disease
Cystic Dibrosis
Hemophilia B
Parkinson's Disease
Global Adeno-Associated Virus Vectors in Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues share in global market, 2022 (%)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amicus Therapeutics
Asklepios Biopharmaceutical
BioMarin Pharmaceutical
Coave Therapeutics
MeiraGTx
Neurocrine Biosciences
Pfizer
Roche Holding
Sangamo Therapeutics
Sarepta Therapeutics
Spark Therapeutics
Voyager Therapeutics
NightstaRx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adeno-Associated Virus Vectors in Gene Therapy, market overview.
Chapter 2: Global Adeno-Associated Virus Vectors in Gene Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Adeno-Associated Virus Vectors in Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adeno-Associated Virus Vectors in Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adeno-Associated Virus Vectors in Gene Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
